Efficacy and safety of short-term dual antiplatelet therapy (≤6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of short-term dual antiplatelet therapy (≤6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis of randomized controlled trials

Published:2018-11 Issue:11 Volume:41 Page:1455-1462
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Misumida Naoki¹^ORCID,Abo-Aly Mohamed¹,Kim Sun Moon¹,Ogunbayo Gbolahan O.¹,Abdel-Latif Ahmed¹^ORCID,Ziada Khaled M.¹

Affiliation:

1. Division of Cardiovascular Medicine, Gill Heart and Vascular Institute; University of Kentucky; Lexington Kentucky

Funder

University of Kentucky Clinical and Translational Science Pilot Award

UK COBRE Early Career Program

National Institutes of Health Grant

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.23075/fullpdf

Reference29 articles.

1. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;Circulation,2016

2. Second-generation drug-eluting stent implantation followed by 6- Versus 12-month dual antiplatelet therapy;Colombo;J Am Coll Cardiol,2014

3. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents;Feres;JAMA,2013

4. Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: a systematic review and meta-analysis of randomized trials;Ziada;Catheter Cardiovasc Interv,2016

5. The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents;Kukreja;JACC Cardiovasc Interv,2009

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?;Journal of Cardiology;2024-08

2. Strategies for chronic coronary disease: A brief guide for clinicians;npj Cardiovascular Health;2024-06-04

3. Development of the first Iranian clinical practice guidelines for the diagnosis, treatment, and secondary prevention of acute coronary syndrome;Journal of Research in Medical Sciences;2024-05

4. Tailoring antiplatelet therapy in older patients with coronary artery disease;Platelets;2023-12-05

5. Dual Antiplatelet Therapy: A Concise Review for Clinicians;Life;2023-07-18